Virus therapy tested as last hope for tough cancers

NCT ID NCT06380309

Recruiting now Disease control Sponsor: Peking University Source: ClinicalTrials.gov ↗

First seen Jan 11, 2026 · Last updated Apr 10, 2026 · Updated 14 times

Summary

This early-stage study is testing the safety and initial effects of a new treatment called IDOV-SAFE in people with advanced digestive system cancers (like colon, stomach, or liver cancer) that have stopped responding to standard therapies. The treatment involves injecting a modified virus into the bloodstream, with the goal of helping the immune system fight the cancer. Researchers will test different doses and combinations with other cancer drugs to find the safest and most effective approach.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED MALIGNANT SOLID TUMOR OF DIGESTIVE SYSTEM are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Beijing Cancer Hospital
RECRUITING

Beijing, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

ADVANCED MALIGNANT SOLID TUMOR OF DIGESTIVE SYSTEM